Cargando…

Inflammatory and immunological profiles in patients with COPD: relationship with FEV (1) reversibility

OBJECTIVE: To determine whether COPD severity correlates with sputum cell counts, atopy, and asthma. METHODS: This was a cross-sectional study involving 37 patients with COPD and 22 healthy subjects with normal lung function (controls). Sputum cell counts were determined by microscopy after centrifu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Queiroz, Cleriston Farias, Lemos, Antonio Carlos Moreira, Bastos, Maria de Lourdes Santana, Neves, Margarida Célia Lima Costa, Camelier, Aquiles Assunção, Carvalho, Natália Barbosa, de Carvalho, Edgar Marcelino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063439/ https://www.ncbi.nlm.nih.gov/pubmed/27832230 http://dx.doi.org/10.1590/S1806-37562015000000122

Ejemplares similares

Evaluation of atopy in patients with COPD
por: Neves, Margarida Célia Lima Costa, et al.
Publicado: (2013)

Lung function in the absence of respiratory symptoms in overweight children and adolescents
por: de Assunção, Silvana Neves Ferraz, et al.
Publicado: (2014)

COPD assessment test and FEV(1): do they predict oxygen uptake in COPD?
por: Carvalho-Jr, Luiz Carlos S, et al.
Publicado: (2018)

Reliability of the Brazilian Portuguese version of the fatigue severity scale and its correlation with pulmonary function, dyspnea, and functional capacity in patients with COPD
por: Valderramas, Silvia, et al.
Publicado: (2013)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Accuracy of the Timed Up and Go test for predicting sarcopenia in elderly hospitalized patients
por: Martinez, Bruno Prata, et al.
Publicado: (2015)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
por: dos Santos, Natasha Cordeiro, et al.
Publicado: (2022)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Frequency of sarcopenia and associated factors among hospitalized elderly patients
por: Martinez, Bruno Prata, et al.
Publicado: (2015)

Utility of FEV(1)/FEV(6) index in patients with multimorbidity hospitalized for decompensation of chronic diseases
por: Komal, Shakeel, et al.
Publicado: (2019)

Influence of HTLV-1 in the clinic, microbiologic and immunologic features of tuberculosis
por: de Lourdes S Bastos, Maria, et al.
Publicado: (2011)

Longitudinal FEV(1) and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
por: Zhudenkov, Kirill, et al.
Publicado: (2021)

Evidence of the association between adherence to treatment and mortality among patients with COPD monitored at a public disease management program in Brazil
por: de Moreira, Aramís Tupiná Alcantara, et al.
Publicado: (2021)

Consequences of the association between HTLV-1 and tuberculosis
por: de Lourdes Santana Bastos, Maria, et al.
Publicado: (2015)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

Estimation of TGF-β1 genotypes in Egyptian smokers; association with FEV(1) in COPD patients
por: Bohy, Mohammad El, et al.
Publicado: (2010)

A novel CT-emphysema index/FEV(1) approach of phenotyping COPD to predict mortality
por: Loh, Li-Cher, et al.
Publicado: (2018)

Changes in FEV(1) over time in COPD and the importance of spirometry reference ranges: the devil is in the detail
por: Kirkby, Jane, et al.
Publicado: (2019)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil
por: de Siqueira, Isadora Cristina, et al.
Publicado: (2021)

Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis
por: Bastos, Maria de Lourdes, et al.
Publicado: (2012)

Finding the Best Thresholds of FEV(1) and Dyspnea to Predict 5-Year Survival in COPD Patients: The COCOMICS Study
por: Almagro, Pere, et al.
Publicado: (2014)

Prevalence and influence of tuberculosis in the neurologic manifestations of the Human T cell lymphotropic virus type 1 (HTLV-1)
por: de Lourdes Bastos, Maria, et al.
Publicado: (2014)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Annual FEV(1) changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study
por: Takahashi, Toru, et al.
Publicado: (2014)

FEV(1) inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure
por: Montaño, Martha, et al.
Publicado: (2014)

Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV(1) in COPD patients
por: Huang, Cuiping, et al.
Publicado: (2013)

Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study
por: Zendedel, Abolfazl, et al.
Publicado: (2015)

Longitudinal change of FEV(1) and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD
por: Jo, Yong Suk, et al.
Publicado: (2019)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0la8fc60rq8dke50l9l8saoniq